# Distalmotion: company

Canonical ID: `bba39508-3e95-4e2f-b736-9bd5ff7e567b`

## Key facts

- **Product:** Dexter hybrid laparoscopic surgical robot (robotic <-> manual mid-procedure); ASC cost-efficiency.
- **Gating events:** CE Dec 2020; FDA De Novo Oct 2024 (inguinal hernia) + cholecystectomy + hysterectomy.

- **Slug:** distalmotion
- **Status:** private (raised $150M Nov 2025)
- **Founded:** 2012
- **HQ:** Lausanne, Switzerland

## Models

- [Dexter](/models/distalmotion-dexter.md) (surgical) (id: `93cb82fd-9fa8-40f5-931c-2d36a8689fb9`)

## Supplies to

_No verified supply relationships on file. Supply-chain coverage is being added across the registry; check back as the seed populates this company's outbound edges._

_Outbound supply edges. Each appears when verified with at least two strong sources. Sources are append-only; corrections add new sources rather than rewrite history._

## Sources (4)

1. https://www.biospace.com/distalmotion-dexter-fda-de-novo
2. https://www.bioworld.com/articles/distalmotion-ce-mark-dexter
3. https://www.globenewswire.com/news-release/2025/11/18/distalmotion-150-million
4. https://www.massdevice.com/distalmotion-dexter-fda-clearance/

_API: GET /v1/companies/bba39508-3e95-4e2f-b736-9bd5ff7e567b · canonical URL: /companies/distalmotion_